Buscar
Mostrando ítems 1-10 de 18
Análisis clínico e histopatológico de la prevalencia de enfermedades cardiacas en muerte súbita. Estudio en autopsias
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2020-04-06)
Effect of left intraventricular pressure on magnitude of vascular waterfall in the epicardial coronary veins
(1990)
Study objective: The aim was to test the hypothesis of a vascular waterfall in the epicardial veins due to compression by the left ventricular (LV) pressure. If this were so, the epicardial venous pressure should be a ...
Effect of left intraventricular pressure on magnitude of vascular waterfall in the epicardial coronary veins
(Oxford University Press, 1990)
Study objective - The aim was to test the hypothesis of a vascular waterfall in the epicardial veins due to compression by the left ventricular (LV) pressure. If this were so, the epicardial venous pressure should be a ...
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: Results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
(Oxford AcademicReino Unido, 2021-08-14)
Aims. Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) events by 24% in
12 705 participants at intermediate CV risk after 5.6 years. There was no benefit of blood pressure (BP) ...
Outcomes of extracorporeal life support for the treatment of acute massive pulmonary embolism: a systematic review
(Elsevier, 2020)
Background: Massive pulmonary embolism (PE) can cause hemodynamic instability leading to high mortality. Extracorporeal life support (ECLS) has been increasingly used as a bridge to definitive therapy. This systematic ...
Novel Approaches in Primary Cardiovascular Disease Prevention : The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics
(2016-03)
Résumé
Introduction
Il est possible de faire baisser efficacement et en toute sécurité le cholestérol et la pression artérielle (PA) avec les statines et les antihypertenseurs tout en réduisant de 20 à 30 % les manifestations ...
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
(2016-04-26)
BACKGROUND
Antihypertensive therapy reduces the risk of cardiovascular events among high-risk
persons and among those with a systolic blood pressure of 160 mm Hg or higher,
but its role in persons at intermediate risk ...
Blood-pressure and cholesterol lowering in persons without cardiovascular disease
(2016-04-02)
BACKGROUND
Elevated blood pressure and elevated low-density lipoprotein (LDL) cholesterol increase the risk of cardiovascular disease. Lowering both should reduce the risk of cardiovascular events substantially.
METHODS
In ...